Collectively, our data establish that perturbing mitochondrial function by DOXY-mediated targeting of mitochondrial protein synthesis triggers the mitochondrial ISR which in the context of MYC-driven neuroblastoma efficiently overcomes existing multidrug resistance mechanisms and eradicates aggressive tumor cells without inducing clinically relevant resistance (Fig. 8c). The gene discussed is MYC; the disease is neuroblastoma.